Table 4.

Development stage of DOAC dashboard

	Inpatient	Outpatient
	Non-VHA (n = 52)	Non-VHA (n = 133)	VHA (n = 55)
	Count (%)	Count (%)	Count (%)	p Value†
Development stage of DOAC dashboard
Initial development/testing	5 (9.6%)	12 (9.0%)	2 (3.6%)	< 0.001‡
Limited pilot use underway	2 (3.8%)	5 (3.8%)	0 0.0%)
Regular clinical use for subset	5 (9.6%)	10 (7.5%)	2 (3.6%)
Regular clinical use for most eligible patients	9 (17.3%)	13 (9.8%)	49 (89.1%)
None or Other	31 (59.6%)	93 (69.9%)	2 (3.6%)

^†Statistical tests compared outpatient groups only

^‡Statistical test performed across group of response options

DOAC direct oral anticoagulant, VHA veterans health administration